Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Pneumonia Article
This is a selection made from among articles on Drug Treatment Pneumonia. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug Addiction and the Family
from:When a family is dealing with drug addiction, everyone is affected. Having an addict in the family can put stress and strain on all relationships as well as the family dynamics. The addiction causes pain, frustration, and anger in all members involved. Because it does affect everyone, the need for family therapy is so important.
There are many emotions involved in a family when dealing with drug addiction. You may find yourself feeling angry toward the addict. This is normal. You wonder how this happened, why it happened, and what you could have done to stop it.
You may feel depressed and helpless, even responsible for your loved one’s addiction. This too is a normal reaction. Often when someone we love is in pain, such as the pain associated with drug addiction, we tend to look for excuses for their behavior. We take the pain on for them and don’t make them take responsibility for their actions.
To begin with, realize that this is a huge mistake. The person with the drug addiction was the one who brought it into your family in the first place, and he or she needs to take responsibility for that. It’s not easy and will be painful for all involved, but once the addict realizes that their actions have consequences, they can take charge of their recovery fully.
Family therapy is a great way to help with drug addiction. Family therapy consists of all members of the family getting together with the assistance of a trained professional and talking about the issues that all are having when it comes to the addict and the addiction itself. Family therapy can be intense but amazingly therapeutic as well. It’s the perfect time to air your feelings in a safe setting with the help of a moderator to keep things on track.
Family and friends can play critical roles in motivating loved ones with an addiction to enter and stay in treatment. Family therapy is important – especially with teen addicts. Having the involvement of family members in a person’s treatment program can strengthen and extend the benefits of the addict’s treatment program.
Drug addiction and family is a volatile situation, but one that can be faced and addressed with love, caring, and compassion. If your family is affected by drug addiction, be supportive and listen with an open heart. It will help you, those around you, and most important the family member with the addiction.
Drug Treatment Pneumonia Specific links
Drug Treatment Pneumonia News
FDA staff question Pfizer arthritis drug benefits
WASHINGTON (Reuters) - U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections. The Food and Drug Administration staff said the drug, called tofacitinib, appeared to reduce swollen and tender joints during clinical trials. But the staff questioned the method of analyzing X ...
Read more...Novartis Drug Afinitor® Approved By FDA As First Medication To Treat Patients With Non-Cancerous Kidney Tumors ...
Novartis Pharmaceuticals Corporation ("Novartis") announced today that the US Food and Drug Administration (FDA) approved Afinitor® (everolimus) tablets* for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery(2).
Read more...FDA staff question benefits of Abbott rival's arthritis drug
(Reuters) — U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections.
Read more...Cottage Grove inmate died of aspiration pneumonia, autopsy finds
Oregon State Police spokesman Lt. Gregg Hastings said 24-year-old Nathan Scott Cooper was released from the jail receive medical treatment for drug withdrawal. He failed to return to the jail at the appointed time and was arrested April 30 and booked back into the jail. Saturday morning at around 5 a.m., jailers found Cooper dead in his cell.
Read more...Basilea participates in public-private collaboration to tackle antibiotic resistance
Basel, Switzerland, May 25, 2012 - Basilea Pharmaceutica Ltd. welcomes the launch in Europe of a pioneering approach to antibiotic research that will see pharmaceutical and biotechnology companies working ...
Read more...Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of ...
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved an expanded dose range for LATUDA in the treatment of adult patients with schizophrenia.
Read more...Pulmatrix Demonstrates iSPERSE Capabilities for Inhaled Dry Powder Delivery of Antibiotics and Antibodies
Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced that its iSPERSEâ„¢ inhaled drug delivery platform demonstrated the capability to formulate a wide range of drugs for inhaled administration, including antibiotics, antibodies and other macromolecules.
Read more...Popular Antibiotic May Be Responsible For Sudden Cardiac Death
Lawrence LeBlond for RedOrbit.com Azithromycin, a common antibiotic used for treatment of bronchitis, pneumonia, and sexually transmitted diseases (STDs), appears to also boost the risk of sudden cardiac death when compared with no antibiotic treatment, according to a US study on Wednesday. Azithromycin has been available worldwide since the 1980s, but the new study, published in the New England ...
Read more...Pulmatrix Announces Presentations at ATS 2012 International Conference
Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced that six posters on its iCALMâ„¢ and iSPERSEâ„¢ inhaled drug platforms ha
Read more...Press Release
Sunovion Pharmaceuticals Inc. Posted on:05 May 12 Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded dose range for LATUDA in the treatment of adult patients with schizophrenia.
Read more...